Vivos Inc. @VivosIncUSA Twitter profile

Last Seen Profiles

@SciPhilOrg

@ISBedu

@BinorRaja

@pacekodi1

@Dairnough1c9A8

@pacekodi1

@Nishat33333

@sp1noff_FPS

@pacekodi1

@RaysofSunshine

@Rey__me

@ecpj_campaign

@pacekodi1

@wrightt91026178

@tybraxt0n

@samuelsazo13

@OvSin98

@Axe000000007

@bsk_pharmacist

@Baralaserlite

@bokeplokalmalam

@dong2gle

@13thubique

@wunderyogi

@iii0iuo

@GettySport

@yettimilanda

@campbellc438470

@RecepOnal122221

@PenikmatIbuIbu9

@SUPARJO219

@MharsMohammed

@LedleyKingsKna

@eletric_haze

@SammiKnell

@rjsalberg

Vivos Inc.

@VivosIncUSA

4 months

The IDE has been submitted and the full press release may be found on our website #VivoIncUSA #RadioGel #IsoPet #Cancer $RDGL

12

28

84

Vivos Inc.

@VivosIncUSA

6 months

IDE submission is on track, our @RadioGel division for treating cancer in humans is another step closer!! The new RadioGel website will be up by the end of the month! #VivosInc #Radiogel #IsoPet #cancer #PRNT $RDGL

13

20

78

Vivos Inc.

@VivosIncUSA

6 months

We patented Precision Radionuclide Therapy™, we patented 3 forms of radiation Alpha-Gel®, Beta-Gel® and Gamma-Gel®. PRnT™ is a safer, more effective and less invasive cancer treatment. We are saving animals now, humans will be next. $RDGL @RadioGel @IsoPetForCancer #Cancer

1

30

71

Vivos Inc.

@VivosIncUSA

1 month

Update on the IDE and @RadioGel

6

18

72

Vivos Inc.

@VivosIncUSA

7 months

IDE submission involves MANY moving pieces but they are finally starting to come together. Just working on the final details and submission will happen. Our Q1 report is being finalized and will be out on the new Vivos website very soon! #VivosIncUSA #RadioGel $RDGL

12

24

70

Vivos Inc.

@VivosIncUSA

3 months

An update from our Vivos Inc. CEO, Dr. Korenko regarding the IDE application. The FDA has acknowledged they have received the application. It is under interactive review. #Cancer #CancerJourney #CancerAwareness @RadioGel @IsoPet $RDGL

3

21

69

Vivos Inc.

@VivosIncUSA

6 months

Update on the story of our domains, it's been a journey and a day late to secure but we are celebrating the fact we have them now! Previous domains will redirect but here are the FINAL websites! Thank you for your patience! $RDGL #Cancer

14

21

68

Vivos Inc.

@VivosIncUSA

6 months

Another step closer.... #MayoClinic #NewGeneration #CancerTreatment #CancerAwareness #Cancer #RadioGel #VivosIncUSA #IsoPet $RDGL

8

23

66

Vivos Inc.

@VivosIncUSA

6 months

This is Vivos Inc. Our company's mission is to treat cancer in animals and humans worldwide. We hold nearly 30 patents securing us as the leader in radionuclide therapy and we are killing cancer! $RDGL #VivosInc #IsoPet #RadioGel

2

25

67

Vivos Inc.

@VivosIncUSA

4 months

As this quarter ends and a new quarter begins be sure to stay informed with the latest updates from our company. Thank you to those who have already subscribed. We are looking forward to an amazing 2024. #VivosIncUSA #RadioGel #IsoPet #Cancer $RDGL

8

20

61

Vivos Inc.

@VivosIncUSA

1 month

Update from todays Sprint meeting #vivosincusa #cancer #CancerAwareness $RDGL

9

21

56

Vivos Inc.

@VivosIncUSA

6 months

Update - we have new corporate headquarters! April's monthly update will be posted on the website at 3pm PST. Thank you all for your incredible support! #VivosIncUSA #IsoPet #RadioGel #Cancer $RDGL

2

14

57

Vivos Inc.

@VivosIncUSA

10 months

Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the FDA has granted RadioGel Precision Radionuclide Therapy the designation as a Breakthrough Device pursuant to the FDA’s

4

16

56

Vivos Inc.

@VivosIncUSA

2 months

Update from the CEO regarding the ongoing discussions with the FDA. General updates will be posted on this platform as new information becomes available. Subscribe to our newsletter at for important press releases for #RadioGel and #IsoPet $RDGL

6

20

56

Vivos Inc.

@VivosIncUSA

2 months

End of the month update on our @RadioGel division #Cancer $RDGL

5

21

56

Vivos Inc.

@VivosIncUSA

7 months

Vivos Inc. is excited to partner with Benzinga to broaden our reach so more people hear when news of our cancer treatment becomes available for human use! 2024 is going to be a great year! #Cancers #CancerAwareness $RDGL #VivosIncUSA #RadioGel #IsoPet

8

17

56

Vivos Inc.

@VivosIncUSA

5 months

In our efforts to keep our loyal followers up to date our May 2024 Monthly report is out with the extended version on our website under "Monthly Reports". #VivosIncUSA #RadioGel #IsoPet #CancerTreatment $RDGL

8

17

55

Vivos Inc.

@VivosIncUSA

7 months

The stars are aligning and we have so much buzz around the company these days!! @QueTraders is posting a great podcast on the company tomorrow, we had a great meeting with Benzinga AND the new website goes LIVE tomorrow! $RDGL #VivosIncUSA #RadioGel #IsoPet

8

19

54

Vivos Inc.

@VivosIncUSA

21 days

Vivos Inc is pleased to share that @IsoPetForCancer has treated their first exotic animal, a ferret named Soymilk. More updates to follow #IsoPet #PetCancer #Cancer #VivosInc #PRnT $RDGL

1

19

55

Vivos Inc.

@VivosIncUSA

4 months

Happy 4th of July to our loyal followers! Have a great day! #4thofJuly #VivosIncUSA #IsoPet #RadioGel #CancerAwareness #Cancer $RDGL

10

14

54

Vivos Inc.

@VivosIncUSA

6 months

April was a busy month @VivosIncUSA We are grateful for everyone on the team, our advisors, our contractors and our loyal shareholders. We are committed to helping cancer patients with our life changing technology. #PRnT #IsoPet #RadioGel $RDGL

3

19

53

Vivos Inc.

@VivosIncUSA

5 months

Intellectual property is very important to the future of our corporation @VivosIncUSA and as we expand our divisions @IsoPetForCancer and @RadioGel utilizing a safer, more effective cancer treatment. #Cancer #PrecisionRadionuclideTherapy #PRnT $RDGL

2

14

53

Vivos Inc.

@VivosIncUSA

9 months

The update you all have been waiting for! More to come throughout the week… #perservance #CancerResearch #Cancer #cancertherapy #nextgeneration #innovations $RDGL

13

17

52

Vivos Inc.

@VivosIncUSA

1 month

This weeks update for @RadioGel

2

14

52

Vivos Inc.

@VivosIncUSA

4 months

Benzinga posted an article on Vivos Inc. To read the article please visit the link below! #VivosIncUSA #RadioGel #IsoPetn #Cancer #PRnT $RDGL

3

21

51

Vivos Inc.

@VivosIncUSA

9 months

This is big news for our company and we anticipate an exciting 2024! More people means more work can be done to grow the company! Monthly update for January will be posted tomorrow but today help us welcome Brad and LeeAnna to Team Vivos! #teamvivos #isopet #radiogel $RDGL

7

11

51

Vivos Inc.

@VivosIncUSA

6 months

BIG news!!! The University of Wisconsin has completed the certification process and has officially joined the IsoPet® team! Now accepting equine patients! More information on #VivosIncUSA #IsoPet #RadioGel #EquineCancer $RDGL

5

18

51

Vivos Inc.

@VivosIncUSA

7 months

You may have noticed we are promoting our IsoPet® division more than ever these days and this is why... #IsoPet #RadioGel #VivosIncUSA #NewGeneration #CancerTreatment #SavingLives #PetCancer $RDGL

3

15

50

Vivos Inc.

@VivosIncUSA

1 year

Last week Vivos CEO Dr. Mike Korenko and Vivos Chief Science Advisor & Exubrion Therapeutics® COO Dr. Nigel Stevenson attended the 11th International Conference on Isotopes in Saskatoon, Saskatchewan, Canada. There were over 300 participants representing 21 countries. The joint

0

12

48

Vivos Inc.

@VivosIncUSA

7 months

A brief overview of our first quarter. It's been a busy three months as we are updating our websites, certifying new clinics, preparing new marketing material and are on track to open our RadioGel™ division in Q2. #VivosIncUSA #RadioGel #IsoPet $RDGL

6

17

50

Vivos Inc.

@VivosIncUSA

2 months

Breakthrough radiation therapy for pets closes in on FDA clearance | Tri-Cities Area Journal of Business

Breakthrough radiation therapy for pets closes in on FDA clearance

A Richland company’s breakthrough radiation therapy that’s seen success in treating cancer in animals is closing in on FDA clearance.

www.tricitiesbusinessnews.com

0

22

49

Vivos Inc.

@VivosIncUSA

1 year

Precision Radionuclide Therapy (PRnT)™ is our pending trademarked term describing our next-generation non invasive brachytherapy oriented #cancer treatment for inoperable tumors in animals and eventually humans. "If we can see the tumor, and reach it; we can kill it." $RDGL

0

19

47

Vivos Inc.

@VivosIncUSA

7 months

With the introduction of our new website we aim to have more information on our breakthrough technology for killing cancer tumors. Here is a snapshot of what is on the new site. Updates will be continuous so check often! $RDGL

8

16

48

Vivos Inc.

@VivosIncUSA

2 months

August Monthly Update @RadioGel @IsoPetForCancer #Cancer $RDGL

2

20

47

Vivos Inc.

@VivosIncUSA

4 months

Vivos Inc. saw a busy June as our quarter came to a close. This is the June summary, the quarterly report will post on the website next week #VivosIncUSA #IsoPet #RadioGel #Cancer #PRnT $RDGL

1

14

46

Vivos Inc.

@VivosIncUSA

3 months

Here is a summary of July for #VivosIncUSA #IsoPet #RadioGel $RDGL

5

15

46

Vivos Inc.

@VivosIncUSA

10 months

Happy Holidays to our loyal shareholders and supporters across the globe. As we approach certain milestones we’d like to share our appreciation to each and every one of you. We are working on posting more updates and thank you for your patience.

5

9

46

Vivos Inc.

@VivosIncUSA

2 years

Good morning. Our presence last week at the Veterinary Cancer Society (VCS) Conference for @IsoPet_RadioGel was highly successful. Also, yesterday’s FDA meeting went very well for @radiogel . Dr. Mike Korenko will summarize in his monthly update November 1st. $RDGL #business

0

14

46

Vivos Inc.

@VivosIncUSA

4 months

@jsanto2387 @BillZonios @RadioGel Everything is on track to submit the IDE in Q2

6

11

45

Vivos Inc.

@VivosIncUSA

2 years

We’re pleased to post our September 2022 update from President and CEO Mike Korenko, Sc. D. Highlights: Our next meeting with the FDA is scheduled for October 17. We submitted our draft of the new animal test plan for VX-2 tumors in rabbits. $RDGL

7

12

43

Vivos Inc.

@VivosIncUSA

8 months

Treating cancer in humans means regular and extensive training sessions, it's part of the process that we wanted to share! #Cancer #lymph #training #VivosIncUSA #RadioGel #IsoPet #CancerTreatment #MayoClinic #PartOfTheProcess $RDGL

3

16

45

Vivos Inc.

@VivosIncUSA

3 months

Q2 had posted to the website under Monthly Reports. Head to the website for all the latest information on Vivos and @IsoPetForCancer @RadioGel

6

17

45

Vivos Inc.

@VivosIncUSA

8 months

Just a friendly reminder that we are working very hard behind the scenes towards IDE submission, we appreciate all the private messages and enthusiasm and will update here with any new information. We appreciate your support! #VivosInc #IsoPet #RadioGel #CancerTherapy $RDGL

2

14

45

Vivos Inc.

@VivosIncUSA

2 years

Good morning. We're pleased to share CEO Mike Korenko's detailed update of our May 20, 2022 meeting with the @US_FDA . The update is available on our @radiogel website at: #cancer #cancertreatment #Cancers #PRnT #RadioGel #breakthrough #biotech $RDGL

8

9

43

Vivos Inc.

@VivosIncUSA

2 years

We’re pleased to post our October 2022 update from President and CEO Mike Korenko, Sc. D. Two major highlights. The VCS Conference & our current update regarding the @FDA IDE Pre-Submission process for @radiogel . Thank you. $RDGL #cancer #news

0

20

43

Vivos Inc.

@VivosIncUSA

8 months

A summary of our very busy and productive February! We are gearing up for an amazing March! #IsoPet #RadioGel #VivosIncUSA #Cancer #PetCancer #CancerTreatment #RoadToIDE $RDGL

2

11

44

Vivos Inc.

@VivosIncUSA

6 months

We are the leaders in radionuclide therapy! $RDGL

1

16

42

Vivos Inc.

@VivosIncUSA

1 year

Upon a successful IDE submission and clearance for @RadioGel , our plan is to first tackle #thyroid cancer in human clinical trials. We plan on working closely with a few @MayoClinic doctors to accomplish this. Work still to be done. #CancerAwareness #CancerTreatment $RDGL

Mayo Clinic

@MayoClinic

1 year

Nearly 44,000 new cases of thyroid cancer will be diagnosed in the U.S. this year.⁠ ⁠ As thyroid cancer grows, it may cause swelling in your neck, voice changes, difficulty swallowing, and pain in your neck and throat.⁠ ⁠ Learn more:

4

7

23

1

16

41

Vivos Inc.

@VivosIncUSA

2 years

Good morning. We're pleased to share our March 2023 business update on our website blog. Thank you. #cancer #cancertreatment #news #oncology #pets #precisionradiotherapy #biotech #cancerawareness $RDGL #RDGL @radiogel @IsoPet_RadioGel

4

15

41

Vivos Inc.

@VivosIncUSA

2 years

Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy. Full Press Release: $RDGL #horse #news #PressRelease @IsoPet_RadioGel #cancer #cancertreatment #CancerResearch

0

15

39

Vivos Inc.

@VivosIncUSA

4 months

Vivos Inc and @QueTraders have joined forces! The recent articles TradersQue has posted showcase our potential in targeted cancer treatment! Stay tuned… #PRnT #VivosIncUSA #RadioGel #IsoPet #CancerTreatment #SaaS #MedicalAdvancements $RDGL

4

17

41

Vivos Inc.

@VivosIncUSA

2 years

With April 1st falling on Saturday, we’re pleased to announce that our March 2023 Corporate Business update will be posted on Monday, April 3, 2023. Thank you. @radiogel @IsoPet_RadioGel #CancerFree #CancerFreePet #ThinkDifferent $RDGL

6

9

39

Vivos Inc.

@VivosIncUSA

9 months

To treat solid tumors safely, and more effectively, by Precision Radionuclide Therapy™ (PRnT) we need to have these beauties in production and we are moving ahead for Q2 & Q3! #vivosinc #cancertherapy #radiogel #isopet #nextgeneration #PRnt #Y90 $RDGL

3

16

40

Vivos Inc.

@VivosIncUSA

9 months

Another update and another step that was taken during the fourth quarter #cancertherapy #newgenerationtherapy #genotoxicity #radiogel #isopet #innovations #cancer $RDGL

4

18

38

Vivos Inc.

@VivosIncUSA

9 months

We are dedicated to increasing our presence in the animal sector. We have 7 clinics across the USA using Precision Radionuclide TherapyTM. As we move forward @VivosIncUSA marketing the technology to save animals is another stepping stone in the process. #radiogel #isopet $RDGL

4

17

39

Vivos Inc.

@VivosIncUSA

8 months

This positive post is needed today…IsoPet® is our division that is saving the lives of animals and the stronger this part of our company is the stronger we will be as a whole. #CancerTherapy #StayPositive #IsoPet #RadioGel #VivosInc $RDGL

3

14

40

Vivos Inc.

@VivosIncUSA

1 year

When it comes to treating solid tumors safely in cats, dogs, and horses – @IsoPet_RadioGel is succeeding. Harnessing the proven medical device technology of @RadioGel ™ to safely treat animal #cancer , is also providing us with invaluable data that demonstrates how we may treat

1

15

38

Vivos Inc.

@VivosIncUSA

2 years

We are pleased to share our February 2023 business update and recap on our website blog. Thank you. $RDGL #cancer #cancertreatment #news #oncology #precisionradiotherapy #biotech #cancerawareness @radiogel @IsoPet_RadioGel

0

7

38

Vivos Inc.

@VivosIncUSA

2 months

Update from the CEO $RDGL

13

10

39

Vivos Inc.

@VivosIncUSA

9 months

For those who haven’t heard, this is BIG news for our fourth quarter of 2023, another step closer! #cancertherapy #radiogel #breakthroughstatus #humantrials #nextgeneration #isopet #vivosinc #perserverance $RDGL

3

17

37

Vivos Inc.

@VivosIncUSA

8 months

We believe in the financial health of our company and have taken steps to ensure our longevity as we continue to grow our brands! We welcome working with Sullivan Sullutions in 2024! #VivosInc #IsoPet #RadioGel #NextGenerationCancerTherapy $RDGL

4

11

39

Vivos Inc.

@VivosIncUSA

3 months

If you missed our press yesterday please visit our website, We will update on this platform and our website as information becomes available. Thank you for your support during these exciting times. #Cancer #VivosIncUSA @RadioGel $RDGL

7

13

39

Vivos Inc.

@VivosIncUSA

2 years

Design to production. Our Peltier Chiller for IsoPet® & RadioGel™. Dr. Mike Korenko stated, "We will make this equipment available to the Mayo Clinic for human clinical trials and to the therapists in all our current and future regional clinics.” $RDGL

2

13

39

Vivos Inc.

@VivosIncUSA

1 year

Y-90 (Yttrium–90) has been cleared by the FDA in treating #LiverCancer for sometime. The next step is what’s the most effective way to get Y-90 in to the tumor ( @RadioGel ™) for maximum benefit, with the least amount of collateral damage. $RDGL #PRnT #CancerResearch #future

Mayo Clinic Comprehensive Cancer Center

@MayoCancerCare

1 year

October is #LiverCancerAwarenessMonth . Consider sharing this article to raise awareness of #LiverCancer and the latest treatments for the disease.

0

2

11

0

11

37

Vivos Inc.

@VivosIncUSA

5 months

For the most accurate and updated information on Vivos Inc and our divisions @IsoPetForCancer and @RadioGel take a look at our websites! #Cancer #CancerTreatment #PRnT $RDGL

0

17

38

Vivos Inc.

@VivosIncUSA

1 year

For years external beam radiation therapy has been used to treat a variety of #Cancer tumors from outside the body, unfortunately with numerous side effects. With our development of RadioGel™ - IsoPet®, we safely and effectively irradiate the tumor from the inside, with no

0

11

36

Vivos Inc.

@VivosIncUSA

18 days

September Update #Vivos #IsoPet #RadioGel #CancerTreatment # #PRnT $RDGL

7

13

38

Vivos Inc.

@VivosIncUSA

1 year

We've received numerous emails regarding where we are on our timeline in regards to our FDA IDE submission progress with @RadioGel ™. We've chosen to respond to the main inquiries in a question-and-answer format now on our website blog. Thank you.

0

10

38

Vivos Inc.

@VivosIncUSA

2 years

RadioGel™, our Precision Radionuclide Therapy (PRnT™) medical device was just an idea less than a decade ago. With the development of IsoPet®, we've shown our next-generation technology is safe, non-toxic, and effective. Human patients are waiting. $RDGL #Cancer #CancerFree

2

12

38

Vivos Inc.

@VivosIncUSA

2 years

MicroCap Daily featured our company. The article uses previous tweets and press releases about @radiogel & @IsoPet_RadioGel . Please note we did not solicit or pay for this article; nor do they hold a position as per their disclaimer. Thank you. $RDGL

Vivos Inc (OTCMKTS: RDGL) Steady Rise Northbound as IsoPet Therapy for Treating Solid Tumors in...

Vivos Inc (OTCMKTS: RDGL) has been moving steadily northbound in recent trading since a brief dip below $0.05 per share in September. The last news from the Company was at the end of September when...

microcapdaily.com

0

14

36

Vivos Inc.

@VivosIncUSA

1 year

We are pleased to announce the official publication of our patent application: Radiotherapy Gel and Method Preparing The Same. This encompasses the September 2022 application, and the amendment made in January 2023. $RDGL #patents #cancertherapy

Vivos Inc.

@VivosIncUSA

2 years

Our proprietary & patented RadioGel™ and IsoPet® Precision Radionuclide Therapy products future yttrium-90 micro-particles that allow for greater penetration into the tumor. This is next generation treatment. $RDGL #gamechanger #nextgeneration #cancer #cancertreatment #news

1

8

23

0

12

37

Vivos Inc.

@VivosIncUSA

2 years

It's been a short 12 weeks since the #horse 'Chevy' was treated for a 1-pound tumor at the New England Equine Practice Clinic with @IsoPet_RadioGel . Veterinarian Dr. Bill Bradley said, "At 3 months it looks like there is a fair amount of atrophy so we're headed in the right

1

8

36

Vivos Inc.

@VivosIncUSA

1 year

Since 2018, we've been safely and effectively administering *IsoPet® therapy to cats, dogs, and recently horses at university partner hospitals and regional clinics. Thanks to IsoPet®, not only have our animal treatments been successful, but also the recovery times for all

RadioGel™

@RadioGel

1 year

The future of using Precision Radionuclide Therapy in #cancertreatment has great possibilities. Oncologists will inject a safe, non-invasive, precision dose of radioactive #RadioGel into a tumor, and allow it to die from the inside – all without harming adjacent tissue. #cancer

0

14

38

3

14

36

Vivos Inc.

@VivosIncUSA

3 months

We thank you for your support and your positive messages, we will continue to post information and updates as they come! Thank you for following! #cancer #cancertreatment #PRnT #precisionradionuclidetherapy #RadioGel #IsoPet $RDGL

3

11

36

Vivos Inc.

@VivosIncUSA

1 year

Good morning. We're pleased to share our April 2023 business update on our website blog. Thank you. #cancer #cancertreatment #news #oncology #pets #precisionradiotherapy #biotech #cancerawareness $RDGL #RDGL @radiogel @IsoPet_RadioGel

7

35

Vivos Inc.

@VivosIncUSA

9 months

January was a busy month and we are looking forward to an even busier February with a lot more updates and posts! #vivosinc #isopet #radiogel #newgeneration #cancertherapy $RDGL

3

11

36

Vivos Inc.

@VivosIncUSA

2 years

Something in the air. Smells like a #newsday . @radiogel #radiogel $RDGL #PrecisionMedicine #PRnT #cancer #CancerMoonshot #Cancers #CancerResearch

0

8

36

Vivos Inc.

@VivosIncUSA

1 year

We are excited about continually expanding awareness of our @IsoPet_RadioGel #PRnT treatment option to the professional veterinary community. Vivos Inc. will be participating in three upcoming #Veterinary conferences: Washington State Veterinary Medical Association, @WSVMAnews –

0

15

36

Vivos Inc.

@VivosIncUSA

9 months

The full Q4 is up on the website, thank you for your patience as we worked out some website kinks. Lots of positive changes with our websites coming in Q1 $RDGL #radiogel #isopet #vivosinc #cancertherapy

2

9

34

Vivos Inc.

@VivosIncUSA

1 year

When we started developing RadioGel™ for human applications, we couldn't imagine how profound the impact of our device technology would be on treating animal cancer(s) branded IsoPet®; our animal friendly therapy using our RadioGel™ patented, proprietary technology. We're

4

11

34

Vivos Inc.

@VivosIncUSA

2 years

Our supply chain management has been another important focus of our @RadioGel ™ team. Dr. Korenko searches for ways to improve efficiency and reliability to ensure our @IsoPet_RadioGel clinic's and patients' needs are met. $RDGL #Cancer #CancerTreatment

1

8

35

Vivos Inc.

@VivosIncUSA

2 years

We envision a future where our safe, and effective biodegradable #cancertreatments , RadioGel™ & IsoPet®, are readily available on both sides of the Atlantic. We’re on the European radar: Article | – Page 10. #cancer #WorldCancerDay #radiotherapy $RDGL

(PDF) Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and...

PDF | The targeted delivery of anti-cancer drugs and isotopes is one of the most pursued goals in anti-cancer therapy. One of the prime examples of such... | Find, read and cite all the research you...

www.researchgate.net

European Cancer Organisation

@EuropeanCancer

2 years

#WorldCancerDay is around the corner! A day to raise awareness of #Cancer & to encourage advances It's an opportunity for you to know about #INTERACTEUROPE , 🇪🇺 project aiming to improve cancer care through the promotion of team working 🌐 @AndreasC466

0

6

25

1

9

34

Vivos Inc.

@VivosIncUSA

2 years

1). We're pleased to provide an update on our IDE process for @radiogel $RDGL. We've scheduled a meeting with the @FDA , May 20, 2022 to clarify #Yttrium particle containment and our dosimetry calculation technique. ”Dosimetry” refers to the science by which radiation dose is...

1

12

32

Vivos Inc.

@VivosIncUSA

1 year

Vivos CEO Dr. Mike Korenko will be attending the Veterinary Society Conference (VCS) in Reno, NV October 12 - 14, 2023. We’re planning on sharing a Q & A interview with him that will go out in our 3rd Quarter (Q3) update to be issued in the last 1/2 of the month. #Cancer $RDGL

3

6

33

Vivos Inc.

@VivosIncUSA

2 years

In response to an enquiry about patents and copyrights regarding @radiogel ™ – Everything is 100% owned by @VivosIncCo . We no longer rely on Battelle for any intellectual or proprietary technology from the original license. Thank you $RDGL #patent #radiogel #Biotechnology

0

13

33

Vivos Inc.

@VivosIncUSA

2 years

We’ve posted our November ‘22 update from President | CEO Mike Korenko, Sc. D. Highlights: @AAEPHorseDocs Conference and a brief update regarding the ongoing @FDA IDE Pre-Submission process for #RadioGel @radiogel . Thank you. $RDGL #cancer #news

0

9

31

Vivos Inc.

@VivosIncUSA

3 months

Today's press release is up on the website at $RDGL

8

13

34

Vivos Inc.

@VivosIncUSA

9 months

Having a solid Quality Management System is an integral part of business and necessary for the process, the behind the scenes work is ongoing… #cancertherapy #nextgeneration #isopet #vivosinc #radiogel #cancer #innovation #BehindtheScenes $RDGL

2

13

34

Vivos Inc.

@VivosIncUSA

1 year

Just a small Spring update to our #Twitter header. Vivos is the company. @RadioGel ™ and @IsoPet_RadioGel ® are the brands. $RDGL #RDGL #CancerTreatment

0

14

33

Vivos Inc.

@VivosIncUSA

1 year

We’re pleased to post our Q3 Quarterly Update ending September 30, 2023. Please note in addition this comprehensive update has been disseminated as an 8K filing. Thank you. @RadioGel @IsoPet_RadioGel #business #cancer $RDGL

0

7

33

Vivos Inc.

@VivosIncUSA

2 years

As with many companies, a large part of what goes on behind the scenes may be like an iceberg. There's a lot more beneath the surface than what meets the eye. We're no exception. Learn more #news #CancerTreatment #Cancer #brachytherapy #investments $RDGL

5

12

33

Vivos Inc.

@VivosIncUSA

2 years

Before the #CancerMoonshot was launched, we began our quest to bring an improved form of #brachytherapy to the world. We're here. @RadioGel ™ kills #cancer tumors. $RDGL One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity

0

7

31

Vivos Inc.

@VivosIncUSA

2 years

While RadioGel™ Therapy proceeds through its process to treat humans, we're actively treating animals on an increasing basis. This treatment utilized the latest advancements in our patented equipment mentioned in yesterday's Press Release and monthly business update. $RDGL

IsoPet® Cancer Treatment

@IsoPetForCancer

2 years

We’re pleased to share a 4 week post IsoPet® Therapy update on the #horse we treated at our New England Regional Clinic. This was the largest tumor we’ve treated to date with our PRnT™ Therapy. The treated area is ‘contracting’ and beginning to drain a bit. #Cancer #equine

2

19

0

10

32

Vivos Inc.

@VivosIncUSA

1 year

There is always more to a story than meets the eye. Like Precision Radionuclide Therapy (PRnT)™, which silently annihilates cancer tumors from within; elements in progress on our business side of things may sometimes appear invisible. Progress is being made daily. #Cancer

0

7

33

Vivos Inc.

@VivosIncUSA

1 year

Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics

Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional...

Richland WA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that it certified three additional clinics to...

www.globenewswire.com

1

11

32

Vivos Inc.

@VivosIncUSA

1 year

This is the new Next. This #Movember , genotoxicity testing with @RadioGel ™ will commence and be conducted in parallel to our previously scheduled additional VX tumor testing. #CancerResearch #CancerTreatment #NextGeneration #PRnT #Cancer $RDGL

1

11

33

Vivos Inc.

@VivosIncUSA

2 years

We are pleased to share our January 2023 business recap and update on our website leading up to #WorldCancerDay . $RDGL #cancer #cancertreatment #news #oncology #precisionradiotherapy #biotech #cancerawareness #WorldCancerDay2023

3

11

33

Vivos Inc.

@VivosIncUSA

8 months

Vivos Inc. would like to take today to recognize International Women's Day and this year’s theme, Inspire Inclusion “Invest in Women: Accelerate Progress” Together we will make the world a better place. #VivosIncUSA #IsoPet #RadioGel #IWD2024 $RDGL

1

10

33

Vivos Inc.

@VivosIncUSA

2 years

RadioGel™ is an yttrium-90 (90Y) based injectable Precision Radionuclide Therapy (PRnT)® medical device for the treatment of cancerous tumors in animals (IsoPet®) and humans (RadioGel™). Our multi-patented Precision Radionuclide Therapy (PRnT)® uses highly localized

1

10

33